雜志介紹

Journal Of Thrombosis And Thrombolysis雜志介紹

《Journal Of Thrombosis And Thrombolysis》是一(yi)本以English為主的(de)(de)未開放獲(huo)取國際優秀期刊(kan)，中文名(ming)稱血(xue)栓(shuan)形成(cheng)和溶栓(shuan)雜(za)志，本刊(kan)主要出版、報道醫學-HEMATOLOGY領(ling)(ling)(ling)域(yu)(yu)(yu)的(de)(de)研(yan)究動態(tai)以及在該(gai)(gai)領(ling)(ling)(ling)域(yu)(yu)(yu)取得(de)的(de)(de)各方面的(de)(de)經驗(yan)和科(ke)研(yan)成(cheng)果，介紹該(gai)(gai)領(ling)(ling)(ling)域(yu)(yu)(yu)有關(guan)本專(zhuan)業(ye)(ye)的(de)(de)最新進展(zhan)(zhan)，探(tan)討行業(ye)(ye)發展(zhan)(zhan)的(de)(de)思路和方法，以促(cu)進學術信息交流，提高行業(ye)(ye)發展(zhan)(zhan)。該(gai)(gai)刊(kan)已被(bei)國際權威數據庫(ku)SCIE收錄(lu)，為該(gai)(gai)領(ling)(ling)(ling)域(yu)(yu)(yu)相關(guan)學科(ke)的(de)(de)發展(zhan)(zhan)起到了良好的(de)(de)推動作(zuo)用，也得(de)到了本專(zhuan)業(ye)(ye)人員的(de)(de)廣泛認(ren)可。該(gai)(gai)刊(kan)最新影響因子(zi)為2.3，最新CiteScore 指數為9.2。

本刊(kan)近期中國學(xue)者發表的(de)論文主要有：

• Safety and efficacy of fibrinogen concentrate in aortic arch surgery involving moderate hypothermic circulatory arrest

  Author: Guan, Xinliang; Li, Lei; Lu, Xuran; Gong, Ming; Li, Haiyang; Liu, Yuyong; Jiang, Wenjian; Lan, Feng; Wang, Xiaolong; Zhang, Hongjia

• Delayed neurological improvement after endovascular treatment for acute large vessel occlusion: data from ANGEL-ACT registry

  Author: Sun, Dapeng; Raynald; Huo, Xiaochuan; Jia, Baixue; Tong, Xu; Ma, Gaoting; Wang, Anxin; Ma, Ning; Gao, Feng; Mo, Dapeng; Miao, Zhongrong

• Empagliflozin activates JAK2/STAT3 signaling and protects cardiomyocytes from hypoxia/reoxygenation injury under high glucose conditions

  Author: Zhang, Fan; Cao, Xudong; Zhao, Chunhui; Chen, Li; Chen, Xiaolin

• Incidence and outcomes of splanchnic vein thrombosis after diagnosis of COVID-19 or COVID-19 vaccination: a systematic review and meta-analysis

  Author: Zheng, Xiaojie; Gao, Fangbo; Wang, Le; Meng, Yao; Ageno, Walter; Qi, Xingshun

英文介紹

Journal Of Thrombosis And Thrombolysis雜志英文介紹

The Journal of Thrombosis and Thrombolysis is a long-awaited resource for contemporary cardiologists, hematologists, vascular medicine specialists and clinician-scientists actively involved in treatment decisions and clinical investigation of thrombotic disorders involving the cardiovascular and cerebrovascular systems. The principal focus of the Journal centers on the pathobiology of thrombosis and vascular disorders and the use of anticoagulants, platelet antagonists, cell-based therapies and interventions in scientific investigation, clinical-translational research and patient care.

The Journal will publish original work which emphasizes the interface between fundamental scientific principles and clinical investigation, stimulating an interdisciplinary and scholarly dialogue in thrombosis and vascular science. Published works will also define platforms for translational research, drug development, clinical trials and patient-directed applications. The Journal of Thrombosis and Thrombolysis' integrated format will expand the reader's knowledge base and provide important insights for both the investigation and direct clinical application of the most rapidly growing fields in medicine-thrombosis and vascular science.